Streptozotocin (STZ)

[Edit]

Streptozocin; Zanosar

Streptozotocin (STZ)
Streptozotocin is a naturally occurring chemical that is particularly toxic to the insulin-producing beta cells of the pancreas in mammals. It is used in medicine for treating certain cancers of the Islets of Langerhans and used in medical research to produce an animal model for Type 1 diabetes in large dose as well as Type 2 diabetes with multiple low doses. Streptozotocin is a glucosamine-nitrosourea compound. As with other alkylating agents in the nitrosourea class, it is toxic to cells by causing damage to the DNA, though other mechanisms may also contribute. DNA damage induces activation of poly ADP-ribosylation, which is likely more important for diabetes induction than DNA damage itself. Streptozotocin is similar enough to glucose to be transported into the cell by the glucose transport protein GLUT2, but is not recognized by the other glucose transporters.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Streptozotocin (STZ) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Streptozotocin (STZ) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Streptozotocin (STZ) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Streptozotocin (STZ) CLIA Kit Customized Service Offer
n/a ELISA Kit for Streptozotocin (STZ) ELISA Kit Customized Service Offer